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Abstract Fibroblast growth factor receptor (class IV) shares a
certain degree of similarity with class III members like platelet-
derived growth factor and macrophage-colony-stimulating factor
receptors, which, once activated, are substrates of low Mr
phosphotyrosine protein phosphatase. Up until now no phospho-
tyrosine phosphatase has been shown to act on this receptor in
vivo. Here we demonstrate that low Mr phosphotyrosine protein
phosphatase is able to reduce receptor tyrosine phosphorylation
and cell proliferation in response to basic fibroblast growth
factor. Contrary to what was previously observed for platelet-
derived growth factor, during cell stimulation with basic
fibroblast growth factor, no enzyme redistribution among cellular
compartments is observed.
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1. Introduction
Evidence has been provided to support the hypothesis that
localization is the most important factor in£uencing phospho-
tyrosine protein phosphatase (PTP) target selection [1^3]. The
analysis of the sequences outside the catalytic domain of PTPs
revealed a great variety of structures which may serve to reg-
ulate their targeting to a subcellular location, thereby restrict-
ing the range of available substrates.
Low Mr PTP (18 kDa) was previously considered a cyto-
solic enzyme, but we recently demonstrated that, at least in
NIH/3T3 ¢broblasts, it also resides in the Triton X-100-in-
soluble fraction, usually identi¢ed as the cytoskeleton [4,5].
Up until now low Mr PTP has been shown to interact in
vivo only with proteins which reside in the particulate frac-
tion: low Mr PTP is phosphorylated by pp60src [6], Lck and
Fyn [7] and it dephosphorylates platelet-derived growth factor
receptor (PDGFr) and macrophage-colony-stimulating factor
receptor (M-CSFr) (class III receptors) [5,8]. A corresponding
reduction in the mitogenic response to PDGF and M-CSF
was also observed. Low Mr PTP activity upon epidermal
growth factor receptor (EGFr) (class I receptor) has been
previously evidenced in vitro [9], but we showed that this
has no correspondence in vivo [10].
We recently demonstrated that low Mr PTP undergoes a
redistribution from the cytosol to the Triton X-100-insoluble
fraction following cell stimulation with PDGF, and that in
this fraction low Mr PTP exerts most of its activity on PDGFr
[4]. This phenomenon, in contrast, was not observed with
EGF and, correspondingly, no e¡ect on EGFr activation
was observed [10]. These ¢ndings, taken together with the
fact that EGFr is a substrate for this PTP in vitro, i.e. in a
condition where the necessity of enzyme compartmentaliza-
tion is overcome, seemed to stress the importance of intra-
cellular localization of low Mr PTP in the de¢nition of en-
zyme speci¢city in vivo.
The high a⁄nity ¢broblast growth factor receptor (FGFr)
family includes several members which bind more than one
type of FGF. These receptors, though being allocated to a
separate class (class IV), share several structure similarities
with the members of class III, such that the ¢rst identi¢ed
gene encoding FGFr was called £g, which stands for ‘fms-
like gene’, where fms is the gene encoding M-CSFr.
Here we demonstrate that these similarities extend also to
the susceptibility of FGFr to low Mr PTP, as both receptor
phosphorylation and mitogenic response elicited by the bind-
ing of basic FGF (bFGF) were a¡ected by phosphatase over-
expression. To our knowledge, this represents the ¢rst re-
ported e¡ect of a tyrosine phosphatase on FGFr
phosphorylation. When we veri¢ed the connection between
the activity of low Mr PTP and its translocation in response
to M-CSF or bFGF, no redistribution of the phosphatase was
observed.
2. Materials and methods
2.1. Cell culture
NIH/3T3 murine ¢broblasts were cultured in Dulbecco’s modi¢ed
Eagle’s medium (DMEM) containing 4.5 g/l glucose, supplemented
with 10% (v/v) fetal calf serum (FCS) (complete medium). BAC-
1.2F5 murine macrophages were cultured in DMEM supplemented
with 10% FCS and 3000 U/ml human recombinant M-CSF. Low
Mr PTP-overexpressing NIH/3T3 (NIH/3T3-PTP) and controls had
been previously obtained through calcium phosphate precipitation
transfection and characterized [11]. In order to maintain stable en-
zyme expression cells were periodically cultured in selective medium
containing 400 Wg/ml G418 (Sigma).
2.2. Determination of the mitogenic response to bFGF in
PTP-expressing NIH/3T3 and controls
1.5U104 cells/cm2 were plated in complete medium on multi-well
dishes and allowed to adhere for 3 h. Medium was then changed and
cells were grown for the subsequent 72 h in DMEM containing 0.5%
FCS and 100 ng/ml bFGF (Boehringer Mannheim). Every 24 h, cell
number was determined using a Bu«rker chamber and the remaining
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wells were supplemented with fresh medium. Every experimental point
was assessed in quadruplicate.
2.3. Stimulation of cells with mitogens
Fibroblasts were grown to sub-con£uence, serum-starved for 24 h
and then stimulated with bFGF for the indicated times. To up-regu-
late M-CSFr expression, macrophages were maintained in medium
containing 10% FCS, deprived of M-CSF, for 18 h prior to growth
factor addition. To stop growth factor stimulation, dishes were placed
on ice and rapidly washed twice with PBS (10 mM Na2HPO4, 150 mM
NaCl, pH 7.4) supplemented with 100 WM sodium vanadate.
2.4. Analysis of the tyrosine phosphorylation pattern following cell
stimulation with mitogens
The pattern of tyrosine phosphorylation in response to mitogen
stimulation was obtained and evaluated as already described [10].
The immunorecognition of basic FGFr (bFGFr) was performed on
the same membrane, following incubation for 30 min at 50‡C in
stripping bu¡er (62.5 mM Tris-HCl pH 6.7, 100 mM 2-mercaptoetha-
nol, 2% (w/v) SDS) and extensive washing, using VBS-7 anti-bFGFr
monoclonal antibody (Calbiochem) according to the procedure cited
above. Note that the antibody used did not allow us to distinguish
between di¡erent types of FGFr capable of interacting with basic
FGF, but NIH/3T3 are known to express predominantly FGFr-1
[12]. A densitometric analysis of bands was performed.
2.5. Cell fractionation and analysis of fractions
The separation of cytosolic, Triton X-100-soluble and -insoluble
fractions was performed as already described [4]. Nuclei were isolated
according to the method described by Schreiber et al. [13]. They were
then lysed through a 10 s sonication in 100 Wl of a 50 mM HEPES pH
7.5 bu¡er, containing 1% (v/v) Triton X-100, 50 mM NaCl, 5 mM
EDTA, 0.5 mM PMSF, 1 mM sodium vanadate, 10 Wg/ml leupeptin,
0.1 mM benzamidine. Nuclear lysates were ¢nally clari¢ed at
10 000Ug for 10 min. The purity and integrity of the nuclear fraction
were con¢rmed assaying 5P nucleotidase activity as a marker of plas-
ma membranes, and acid phosphatase activity as a marker of lyso-
somes, and evidencing the presence of the typical histonic pattern by
SDS-PAGE and gel staining with Coomassie blue stain (Pierce).
Subcellular fractions from di¡erent samples were normalized for
protein concentration before their subsequent analysis. In order to
determine low Mr PTP distribution, samples were subjected to
12.5% SDS-PAGE and immunoblotting with a polyclonal anti-low
Mr PTP antibody [14] followed by a peroxidase-conjugated anti-rab-
bit antibody (Calbiochem), according to the procedure cited above. A
densitometric analysis of bands was performed.
3. Results
The mitogenic response of NIH/3T3 cells to bFGF was
evaluated by counting at di¡erent times of incubation (Fig.
1). Growth of NIH/3T3-PTP cells was signi¢cantly reduced
compared to that of controls (365% at 72 h).
In order to ascertain the possibility of a negative e¡ect of
low Mr PTP on FGFr phosphorylation, we analyzed the ty-
rosine phosphorylation pattern following cell stimulation with
increasing bFGF doses. As shown in Fig. 2B, the phospho-
rylation of a 110 kDa band was signi¢cantly reduced in NIH/
3T3-PTP (lanes 5^8) compared to control cells (lanes 1^4).
This band was identi¢ed as FGFr by subsequent recognition
with a speci¢c antibody (Fig. 2A); the presence of an equal
receptor amount in the two cell lines was veri¢ed through
densitometric analysis of the bands (not shown). As in Fig.
2 the tyrosine phosphorylation level of several proteins was
identical in NIH/3T3-PTP and in control cells, the possibility
of a general non-speci¢c activity of low Mr PTP due to its
overexpression was excluded.
FGFr is known to migrate from the plasma membrane to
the nucleus during prolonged stimulation with bFGF [12].
Following stimulation with bFGF for up to 40 min, cells
were subjected to fractionation in order to obtain the nuclear
and non-nuclear fractions, and the phosphatase distribution
was determined through electrophoresis and immunoblotting.
Fig. 3 shows that low Mr PTP was uniformly distributed in
the non-nuclear fraction (lanes 1^4), while it was never re-
trieved from the nucleus (lanes 5^8). Under our conditions,
FGFr did translocate to the nucleus, being already detectable
5 min after stimulation (data not shown), in keeping with
Maher et al. [12].
We recently demonstrated [4] that, following NIH/3T3 stim-
Fig. 1. Growth curves of NIH/3T3-PTP and controls following
bFGF stimulation. Cells were plated in complete medium. After 3 h
they were washed and grown in DMEM containing 0.5% FCS and
100 ng/ml bFGF for 3 days. Every 24 h cell number was deter-
mined in quadruplicate and the remaining wells were supplemented
with fresh medium. Data from three independent experiments are
reported as mean þ S.E.M.
Fig. 2. Tyrosine phosphorylation pattern in NIH/3T3-PTP and con-
trols following bFGF stimulation. Cells were serum-starved for 24 h
and then stimulated for 5 min with 20, 40 or 80 ng/ml bFGF. Total
cell lysates were analyzed through SDS-PAGE and Western blotting
followed by ECL detection. A: Immunoblot with anti-FGFr anti-
bodies. B: Immunoblot with anti-phosphotyrosine antibodies. Lanes
1^4: controls; lanes 5^8: NIH/3T3-PTP. Arrow: FGFr. Densito-
metric analysis of phosphorylated FGFr bands: lane 7, 356% com-
pared to lane 3; lane 8, 365% compared to lane 4 (data obtained
using a Quanti Scan (Biosoft) program).
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ulation with PDGF, low Mr PTP translocates from the cyto-
sol to a Triton X-100-insoluble fraction. Cytosol and Triton
X-100-soluble and -insoluble fractions from bFGF-stimulated
cells were analyzed for low Mr PTP distribution. Fig. 4A
shows that an invariant level of low Mr PTP was observed
in both the cytosol and the Triton-insoluble fraction. No en-
zyme was ever detected in the Triton-soluble fraction (that is
in membranes) at these time points of stimulation (not
shown). In a previous study, we demonstrated a reduction
in both the mitogenic response elicited by M-CSF and the
tyrosine phosphorylation of its receptor in N3FP cells, NIH/
3T3 cells arti¢cially induced to express M-CSFr and overex-
pressing low Mr PTP [5]. In this cell line (not shown) and in
BAC-1.2F5 murine macrophages which do not overexpress
the phosphatase, the enzyme distribution among cell fractions
was then analyzed (Fig. 4B). In both cases, following M-CSF
stimulation, an invariant level of low Mr PTP was observed in
the cytosol (1) and in the Triton-insoluble fraction (2), while
no enzyme was detected in the Triton-soluble fraction (not
shown). It is worth noting that the naturally expressed enzyme
in BAC-1.2F5 cells appears as a doublet. The meaning of this
pattern is currently under investigation. On stripping and re-
probing membranes with anti-receptor antibodies, bFGFr and
M-CSFr were clearly displayed in the Triton-insoluble frac-
tion (data not shown), a result never reported before.
4. Discussion
The data presented in this paper demonstrate, for the ¢rst
time, the existence of a phosphotyrosine phosphatase, low Mr
PTP, whose overexpression in cells causes a reduction in the
tyrosine phosphorylation level of activated bFGFr. This de-
phosphorylation produces an attenuation of the mitogenic
signal departing from FGFr, which results in a lower prolif-
erative response to bFGF, compared to control cells.
Our recent studies led us to hypothesize a correlation be-
tween the redistribution of low Mr PTP from the cytosol to
the particulate fraction and PTP activity on a given receptor
[4,10]. The results reported in this paper led us to reconsider
the above hypothesis. As already observed for PDGFr, FGFr
tyrosine phosphorylation was decreased by low Mr PTP over-
expression, but no PTP redistribution was observed upon
bFGF addition. An invariant level of enzyme was detectable
in both the cytosol and the Triton X-100-insoluble fraction,
while it was never retrieved from the Triton-soluble fraction.
We veri¢ed that no PTP translocation in the Triton X-100-
soluble fraction occurred during the very early phase (15 s) of
cell stimulation with bFGF (data not shown). We also ob-
served a similar ‘unresponsiveness’ to M-CSF (M-CSFr is a
substrate of low Mr PTP in vivo [5]), on PTP redistribution in
N3FP ¢broblasts (data not shown) induced to express M-
CSFr and overexpressing low Mr PTP [5] and BAC-1.2F5
murine macrophages, where no overexpression had been in-
duced.
Many data suggest for bFGF a nuclear signalling function
[12,15,16], which would be necessary, together with membrane
receptor phosphorylation, to cause cell proliferation [17,18].
Nuclear translocation of bFGF occurs together with its plas-
ma membrane receptors. The analysis of the nuclear fraction
revealed that no low Mr PTP could ever be detected in it, even
if we prolonged bFGF stimulation for time periods su⁄cient
to induce receptor translocation (data not shown) [12]. This
made us exclude the possibility that the PTP-dependent de-
phosphorylation of FGFr shown in Fig. 2 may be carried out
in the nucleus.
We then concluded that bFGFr and M-CSFr dephospho-
rylation are not accompanied by low Mr PTP redistribution in
a speci¢c compartment. However, it is worth remembering
here that the dephosphorylation of PDGFr was evident in
the Triton-insoluble fraction (where low Mr PTP is redistrib-
uted following cell stimulation with PDGF), but also detect-
able in the Triton-soluble fraction (where PTP was never
found) [4]. These results are understandable considering the
contiguity of cytosol and membrane, which renders mem-
brane-associated proteins accessible substrates for soluble en-
zymes. Thus, low Mr PTP displays a certain degree of in vivo
substrate speci¢city that is achieved through a mechanism
which does not necessarily involve a translocation of the en-
zyme. The latter event appears, at this point, to be a peculiar
consequence of PDGF stimulation, whose meaning is cur-
rently under investigation.
Other considerations can be made concerning the ability of
low Mr PTP to select its substrates. Jia et al. [19] showed the
importance of the residues lining the deep crevice containing
the active site in the de¢nition of substrate speci¢city of sev-
eral PTPs. In low Mr PTP these residues are mainly hydro-
phobic, and this seems to determine a clear preference of this
enzyme for substrates containing two hydrophobic residues at
Fig. 4. Low Mr PTP distribution following stimulation with bFGF
or M-CSF. Serum-starved ¢broblasts (A) or macrophages deprived
of M-CSF for 18 h (B) were stimulated with 40 ng/ml bFGF or
5000 U/ml M-CSF, respectively, for 0, 5, 10 or 15 min. Cell frac-
tions were analyzed by SDS-PAGE and immunoblotting with anti-
low Mr PTP antibodies, followed by ECL detection. 1: cytosol;
2: Triton X-100-insoluble fraction.
Fig. 3. Low Mr PTP distribution in the nuclear and non-nuclear
fractions, in PTP-overexpressing NIH/3T3. Cells were stimulated for
the indicated time periods and then subjected to fractionation. Nu-
clear and non-nuclear fractions were analyzed by SDS-PAGE and
immunoblotting with anti-low Mr PTP antibodies. Lanes 1^4: non-
nuclear fraction; lanes 5^8: nuclear fraction; lane 9: control low
Mr PTP.
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the phosphotyrosine N-side. A recent study demonstrates that,
among nine Tyr-phosphorylated peptides containing the se-
quences surrounding the main phosphorylation sites of
L-PDGFr, only one (corresponding to the requisite underlined
above) was a substrate for which low Mr PTP displayed an in
vitro a⁄nity comparable to that typical of a number of other
PTPs [20]. These data, while not excluding the involvement of
an ‘intermediate’ (an adapter protein) allowing the interaction
of low Mr PTP with its substrates, stress the importance of a
sequence-speci¢c recognition which could explain the ob-
served in vivo preferences of this enzyme.
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